2020
Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension?
Turner JM, Kodali R. Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension? Current Cardiology Reports 2020, 22: 95. PMID: 32648000, PMCID: PMC7344347, DOI: 10.1007/s11886-020-01352-8.Commentaries, Editorials and LettersMeSH KeywordsAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsHumansHypertensionRenin-Angiotensin SystemConceptsAngiotensin receptor blockersACE inhibitorsEnzyme inhibitorsReceptor blockersSimilar efficacyAngiotensin converting enzyme (ACE) inhibitorsAdverse effectsAnti-hypertensive medicationsManagement of hypertensionUse of ARBGreater side effectsEqual efficacySide effectsClinical scenariosRecent FindingsInClinical settingARBsPrevious trialsEfficacyHypertensionBlockersInhibitorsTrialsAdvantageous effectsMedications
2017
Blood pressure targets for hemodialysis patients
Turner JM, Peixoto AJ. Blood pressure targets for hemodialysis patients. Kidney International 2017, 92: 816-823. PMID: 28938954, DOI: 10.1016/j.kint.2017.01.038.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsDialysis unit blood pressureHemodialysis patientsBlood pressureBP targetsBlood pressure targetsLarge observational studiesBenefit-risk balanceBP reductionPressure targetsBP managementTreatment strategiesObservational studyCurrent evidenceDialysis providersGeneral populationClinical practicePatientsHypertensionNephrologistsPopulationTargetMortalityTrials